Physician profile
Devon Briggs
NPI 1649259714
$2,055.70
in general payments reported to CMS, 2019-2025
11 companies · $632 in 2025
The $632 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $123 · 2022: $67.79 · 2023: $346 · 2024: $582 · 2025: $632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,554 · Education: $5.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,553.96 |
| Education | $5.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $411.15 | 2024-2025 | Uzedy, Austedo Xr |
| Janssen Pharmaceuticals, INC | $396.13 | 2019-2025 | Invega Sustenna, Invega Trinza |
| Otsuka America Pharmaceutical, INC. | $350.63 | 2019-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Lundbeck LLC | $233.46 | 2019-2025 | Abilify Maintena |
| Indivior INC. | $219.86 | 2022-2024 | Perseris |
| Alkermes, INC. | $188.26 | 2019-2025 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $113.25 | 2024-2025 | Caplyta |
| E.R. Squibb & Sons, L.L.C. | $77.11 | 2025 | Cobenfy |
| Supernus Pharmaceuticals, INC. | $28.88 | 2022 | |
| Vertical Pharmaceuticals, LLC | $22.93 | 2019 | |
| Biotissue Holdings INC. | $14.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Briggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.